HOME >> BIOLOGY >> NEWS
UCR entomologists honored for maintaining and enhancing nation's natural resources and environment

RIVERSIDE, Calif. (www.ucr.edu) -- June 27, 2003 -- Entomologist Nick Toscano and Assistant Research Entomologist Matthew Blua in the department of entomology at UC Riverside have been recognized for exemplary service and achievements by Agriculture Secretary Ann M. Veneman at the 57th Annual U.S. Department of Agriculture (USDA) Honor Awards Ceremony held this month in Washington, D.C. Toscano and Blua received the Secretary's Annual Awards in the category 'Maintaining and enhancing the nation's natural resources and environment.'

The Secretary's Annual Honor Awards are the most prestigious awards given by USDA. The University of California's honorees were among this year's 85 award winners. The awards are the most significant recognition the USDA can bestow to acknowledge outstanding contributions to agriculture and to the consumers of agricultural products. The purpose of Honor Awards is to provide high-level recognition to deserving USDA employees at all levels and private citizens who have made outstanding contributions supporting the USDA's mission. The Honor Awards Program was created in 1947.

Toscano and Blua are members of the Cooperative Glassy-winged Sharpshooter (GWSS) Areawide Management Team that developed and implemented pest management strategies against the Glassy-winged sharpshooter in California.

"Our programs suppressed GWSS populations to non-detectable levels in Temecula and Kern County citrus," said Toscano. "The suppression of the GWSS populations was done to reduce the possibility of infecting vineyards bordering citrus with Pierce's Disease. All indications are that the programs in these areas have been very successful."

This is the second USDA group award Toscano has received, the previous being for his participation in the National
'"/>

Contact: Iqbal Pittalwala
iqbal@citrus.ucr.edu
909-787-2645
University of California - Riverside
27-Jun-2003


Page: 1 2

Related biology news :

1. UCR entomologists report bee-dancing brings more food to honeybee colonies
2. Formosan termite may be top concern of entomologists of the new millenium, according to report
3. Leader in cancer treatment and prevention research honored
4. UT Southwestern biochemist honored with NIH Directors Pioneer Award
5. Virginia Tech professor honored with DeLaval Award
6. Major scientific discovery in cancer research to be honored
7. Scientist honored for studies of genetic influence on chemotherapy, tumor development
8. Margaret Foti to be honored for significant contributions to cancer care
9. Stuart Lipton honored with Jung Prize for Medicine
10. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
11. Andres Vazquez-Torres honored with 2004 Merck Irving S. Sigal Memorial Award

Post Your Comments:
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: